Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
October 6, 2006

Affymetrix and NimbleGen Systems Enter into Licensing Agreement

  • NimbleGen Systems obtained a nonexclusive, worldwide license to a number of Affymetrix patents covering the manufacture, use, and sales of nucleic acid microarrays and related products and services in the research field.

    “This licensing agreement with NimbleGen follows from a commercial relationship and enables both companies to better serve customers within the growing microarray market,” says Alan Sherr, vp and chief counsel for licensing at Affymetrix.

  • You’re all set! Thank you for subscribing to GEN Highlights.